Optimizing Treatment for HR+/HER2- Breast Cancer: A Multidisciplinary Approach

Expert oncologists review data presented at recent conferences and discuss current multidisciplinary strategies for the treatment of patients with HR+/HER2- breast cancer.

EP. 11: Utility of Primary Tumor Surgery for De Novo Metastatic Breast Cancer

September 26th 2023

Experts debate the utility of surgery on the primary tumor in patients with novel metastatic HR+/HER- breast cancer.

EP. 12: Unmet Needs in the Treatment of HR+/HER2- Breast Cancer

September 26th 2023

Closing their discussion, the panel shares some remaining unmet needs in the treatment and management of patients with HR+/HER- breast cancer.